Unicycive Therapeutics, Inc.(UNCY:US)
Market Cap$84.8M
Key Metrics
Price$3.36
Revenue (TTM)$0
Holders Revenue (TTM)$0
Gross Profit (TTM)-
Earnings (TTM)-$39.95M
EBITDA (TTM)-$28.14M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$37.37M
Total Assets$64.41M
Net Assets$37.7M
Total Debt$941K
Key Metrics
Price$3.36
Revenue (TTM)$0
Holders Revenue (TTM)$0
Gross Profit (TTM)-
Earnings (TTM)-$39.95M
EBITDA (TTM)-$28.14M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$37.37M
Total Assets$64.41M
Net Assets$37.7M
Total Debt$941K
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | - | - | - | - | - | - | - | $0 | $675K | $0 | $951K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| $8.44M | $7.22M | $7.34M | $6.96M | - | - | - | - | - | - | - | $4.32M | $4.88M | $5.33M | $6.51M | $3.64M | $3.54M | $2.75M | $4.72M | $779K | $731K | $717K | $626K | $336K | $342K | |
| Research and Development | $1.61M | $2.25M | $2.96M | $1.75M | - | - | - | - | - | - | - | $2.27M | $3.03M | $3.84M | $4.8M | $1.86M | $1.93M | $1.36M | $3.78M | $493K | $450K | $382K | $304K | $182K | $148K |
| Selling, General, and Administrative | $6.83M | $4.97M | $4.38M | $5.21M | - | - | - | - | - | - | - | $2.06M | $1.85M | $1.49M | $1.7M | $1.78M | $1.6M | $1.39M | $939K | $286K | $281K | $335K | $322K | $154K | $194K |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$8.44M | -$7.22M | -$7.34M | -$6.96M | - | - | - | - | - | - | - | -$4.32M | -$4.2M | -$5.33M | -$5.55M | -$3.64M | -$3.54M | -$2.75M | -$4.72M | -$779K | -$731K | -$717K | -$626K | -$336K | -$342K |
| -$4.39M | -$7.44M | $1.33M | $516K | $8.35M | -$12.56M | $1.75M | $16.81M | -$11.81M | -$1.61M | $1.4M | $484K | -$10.37M | -$3K | -$3K | $0 | $0 | $0 | -$486K | -$321K | -$233K | -$163K | -$76K | -$2K | -$2K | |
| Non-Operating Interest Income | $394K | $351K | $279K | $155K | - | - | - | - | - | - | - | $234K | $14K | - | $0 | $0 | $0 | - | - | - | - | - | - | - | - |
| Non-Operating Interest Expense | $0 | $27K | $15K | $13K | - | - | - | - | - | - | - | $32K | $12K | $3K | $3K | $0 | $0 | $0 | $55K | $321K | $252K | $163K | $76K | $2K | $2K |
| Other Income/Expense | -$4.78M | -$7.77M | $1.07M | $374K | $8.35M | -$12.56M | $1.75M | $16.81M | -$11.81M | -$1.61M | $1.4M | $282K | -$10.38M | - | - | - | - | $0 | -$431K | - | $19K | - | - | - | - |
Income Before Tax | -$12.82M | -$14.67M | -$6.01M | -$6.45M | - | - | - | - | - | - | - | -$3.84M | -$14.58M | -$5.33M | -$5.56M | -$3.64M | -$3.54M | -$2.75M | -$5.2M | -$1.1M | -$964K | -$880K | -$702K | -$338K | -$344K |
Income Tax | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -$12.82M | -$14.67M | -$6.01M | -$6.45M | - | - | - | - | - | - | - | -$3.84M | -$14.58M | -$5.33M | -$5.56M | -$3.64M | -$3.54M | -$2.75M | -$5.2M | -$1.1M | -$964K | -$880K | -$702K | -$338K | -$344K |
Minority Interests | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | $0 | - | - | $0 | - | - | - | - | - | - | - | $0 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$12.82M | -$14.67M | -$6.01M | -$6.45M | - | - | - | - | - | - | - | -$3.84M | -$14.58M | -$5.33M | -$5.56M | -$3.64M | -$3.54M | -$2.75M | -$5.2M | -$1.1M | -$964K | -$880K | -$702K | -$338K | -$344K |
Shares Outstanding (Basic) | 23.91M | - | 18.07M | 12.3M | 11.68M | - | 8.89M | 37.91M | 34.91M | - | 32.63M | 15.23M | 15.23M | - | 15.06M | 15.03M | 15M | - | 14.17M | 13.98M | 8.58M | - | 8.58M | 8.58M | 14.5M |
Shares Outstanding (Diluted) | 23.91M | - | 18.07M | 12.3M | 12.38M | - | 8.89M | 94.05M | 34.91M | - | 32.63M | 15.23M | 15.23M | - | 15.06M | 15.03M | 15M | - | 14.17M | 13.98M | 8.58M | - | 8.58M | 8.58M | 14.5M |
EPS (Basic) | -$0.54 | - | -$0.33 | -$0.52 | $0 | - | -$0.50 | $0.08 | -$0.61 | - | -$0.13 | -$0.29 | -$0.97 | - | -$0.37 | -$0.24 | -$0.24 | - | -$0.37 | -$0.079 | -$0.11 | - | -$0.082 | -$0.039 | -$0.024 |
EPS (Diluted) | -$0.54 | - | -$0.33 | -$0.52 | -$0.50 | - | -$0.50 | -$0.15 | -$0.61 | - | -$0.13 | -$0.29 | -$0.97 | - | -$0.37 | -$0.24 | -$0.24 | - | -$0.37 | -$0.079 | -$0.11 | - | -$0.082 | -$0.039 | -$0.024 |
EBIT | -$12.82M | -$14.64M | -$6M | -$6.43M | - | - | - | - | - | - | - | -$3.81M | -$14.56M | -$5.33M | -$5.55M | -$3.64M | -$3.54M | -$2.75M | -$5.15M | -$779K | -$712K | -$717K | -$626K | -$336K | -$342K |
EBITDA | -$7.83M | -$6.72M | -$6.92M | -$6.67M | - | - | - | - | - | - | - | -$4.01M | -$4.14M | -$5.28M | -$5.51M | -$3.6M | -$3.5M | -$2.75M | -$4.72M | -$779K | -$731K | -$717K | -$626K | -$336K | -$342K |